Geyer, Holly L <br/><br/>
JAK2 inhibitors and their impact in myeloproliferative neoplasms.  [electronic resource] 

 -  Hematology (Amsterdam, Netherlands)  Apr 2012 
 - S129-32 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1607-8454 
<br/><br/><label>Standard No.: </label>10.1179/102453312X13336169156375  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzamides--pharmacology<br/>Bridged-Ring Compounds--pharmacology<br/>Carbazoles--pharmacology<br/>Furans<br/>Humans<br/>Janus Kinase 2--antagonists & inhibitors<br/>Myeloproliferative Disorders--drug therapy<br/>Nitriles<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyrazoles--pharmacology<br/>Pyrimidines--pharmacology<br/>Pyrrolidines--pharmacology<br/>Sulfonamides--pharmacology